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Over the past decades, life expectancy of patients with
congenital heart disease has dramatically increased.
The prognosis of patients with tetralogy of Fallot
(TOF) was invariably fatal until the development of
palliative and later corrective surgical procedures.
Repaired TOF has an excellent long-term prognosis,
but survival is still suboptimal. Serious complications
may develop late after total repair during infancy.
These complications are usually the result of long-
standing pulmonary regurgitation, leading to
dilatation of the right ventricle, decreased exercise
tolerance, an increased risk for severe arrhythmias,
and even sudden death. Pulmonary valve replacement
has beneficial effects on right ventricular size and
function, provided it is performed early, before
irreversible right ventricular dysfunction ensues.
Moreover, pulmonary valve replacement is associated
with an improvement in patients’ symptoms and
exercise tolerance. Combined with arrhythmia sur-
gery pulmonary valve replacement leads to a dramatic
decrease in the incidence of fatal ventricular arrhyth-
mias. Although late pulmonary valve replacement
offers excellent mid-term results, homografts and
xenografts, usually used for right ventricular outflow
tract reconstruction, suffer late dysfunction and fail-
ure, committing patients and surgeons to further
operations. Therefore, the timing of surgery must be
carefully considered, weighing the up-front risks of
surgery and possible repeat surgery against the risk of
ongoing pulmonary regurgitation [1, 2]. Over the past
years, many investigators have attempted to find the
optimal moment of surgery [3–8], but presently there
are no universally accepted criteria to determine
optimal timing for valved conduit placement in
patients with TOF.
A combination of clinical, electrocardiographic
and imaging criteria is presently used to determine
the timing of valve replacement. Exercise tolerance,
signs of heart failure, prolonged QRS duration play
an important role, but nowadays criteria based on
cardiovascular imaging are gaining increased interest.
In the past 20 years, cardiovascular magnetic reso-
nance (CMR) imaging has become a predominant
tool in the clinical management of patients with
cardiovascular disease [9–15], in particular in
patients with congenital heart disease [16–24].
CMR imaging has evolved into an imaging technique
that provides adequate and unique information on
residual problems in the follow-up of patients oper-
ated for TOF [8]. Spin-echo and gradient-echo CMR
imaging allow detailed assessment of intracardiac
and large vessel anatomy, which is particularly
helpful in TOF patients with residual abnormalities
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of right ventricular outflow and/or pulmonary artery.
Multisection gradient-echo cine CMR can be used to
obtain accurate measurements of biventricular size,
left and right ventricular ejection fraction, and wall
mass. This allows serial follow-up of biventricular
function. Knauth et al. showed that severe right
ventricular dilatation and either left or right ventric-
ular dysfunction assessed by CMR predicted major
adverse clinical events [25].
At present, CMR velocity mapping is the only
imaging technique available that provides practical
quantification of pulmonary regurgitation volume.
CMR velocity mapping can also be used to quantify
right ventricular diastolic function in the presence of
pulmonary regurgitation. Niezen et al. used CMR
imaging to assess right ventricular diastolic function
in young patients with corrected TOF and pulmonary
regurgitation [26]. Nineteen children with repair of
TOF and 12 healthy children were studied using
CMR The authors showed impaired relaxation and
restriction to filling affect right ventricular function in
children with repair of TOF and pulmonary regurgi-
tation. Based on the above-mentioned studies, CMR
imaging may play a key role in indications, accurate
diagnosis and prognosis, and timing of pulmonary
valve replacement after TOF repair [27].
In a recent study, Oosterhof et al. analyzed
preoperative thresholds of right ventricular volumes
above which no decrease or normalization of right
ventricular size takes place after surgery [28]. The
authors studied 71 adult patients with corrected TOF,
who underwent pulmonary valve replacement in a
nationwide, prospective follow-up study. Patients
were evaluated with CMR imaging both preopera-
tively and postoperatively. The authors could not find
a threshold above which right ventricular volumes did
not decrease after surgery. Preoperative right ven-
tricular volumes were independently associated with
right ventricular remodeling and also when corrected
for a surgical reduction of the right ventricular
outflow tract. However, normalization could be
achieved when preoperative enddiastolic volume
was \160 ml/m2 or right ventricular endsystolic
volume was \82 ml/m2.
The purpose of the present study by Greenberg et al.
reported in this issue, was to identify E- and A-wave
flow patterns across the tricuspid valve in TOF patients
[29]. Results from CMR phase contrast velocity-
encoded flow quantification correlated well with
measurements of right ventricular enlargement. The
authors studied 33 children following TOF repair who
had CMR examinations that included cine imaging to
quantify ventricular size and function and flow analysis
across the atria-ventricular valves to evaluate ventricle
in-flow patterns. The E:A ratio was calculated for each
patient and the population was separated into two
different groups: alpha (E:A ratio C 1.4) and beta (E:A
ratio \ 1.4) groups. A significant association was
present between the group with E:A ratio \ 1.4 and
right ventricle enddiastolic volume index C 140 ml/
m2 (P = 0.046), right ventricular endsystolic volume
index C 70 ml/m2 (P = 0.02), and enddiastolic vol-
ume right ventricle to left ventricle C 2.0 (P = 0.003).
A reduction in the E:A wave ratio across the tricuspid
valve was associated with right ventricular diastolic
dysfunction and correlated well with right ventricular
enlargement. The reduction in the E:A wave ratio
across the tricuspid valve may be considered a new
useful criterion for determining the timing of valved
pulmonary conduit surgery in children following TOF
repair.
The decision to operate adult patients with TOF
for pulmonary regurgitation should be based on the
balance between progressive right ventricular dilata-
tion, exercise intolerance, symptoms, the occurrence
of arrhythmias and the fact that further reoperations
will be needed [30–34]. Research on the ideal valve
for right ventricular outflow tract reconstruction is
ongoing. Oosterhof et al. analyzed the long-term
outcomes after pulmonary valve replacement in
patients with a previous correction for TOF [35]. In
a retrospective study, 158 adult patients who had
undergone a pulmonary valve replacement after
initial total correction for TOF in childhood, were
identified from the Dutch CONCOR (CONgenital
CORvitia) registry [36]. All patients underwent
pulmonary valve replacement between June 1986
and June 2005. After 10 years of pulmonary valve
replacement, 47% of the patients were free from
homograft dysfunction and event-free survival after
pulmonary valve replacement was 78%. Significant
residual lesions directly after surgery influenced
event-free survival. A smaller diameter of the
pulmonary homograft and severe pre-surgical pul-
monary regurgitation were related to early homograft
dysfunction after surgery.
Prospective follow-up of patients with TOF with
exercise testing and assessment of right ventricular
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size and function will better define the natural history
of the disease. At present, CMR imaging plays a key
role in assessing ventricular function and volumes,
thereby predicting clinical outcomes and providing
firm guidelines for timing of pulmonary valve
replacement, especially in asymptomatic patients.
The current study of Greenberg et al. [29] provides a
valid additional CMR criterion to determine proper
timing of surgery in adult patients with TOF and
serious pulmonary regurgitation.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
permits any noncommercial use, distribution, and reproduction
in any medium, provided the original author(s) and source are
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